Luis Porrata HeadshotPrincipal Investigator: Dr. Luis Porrata

Disease: Non-Hodgkin Lymphoma

Research Description: Dr. Porrata’s clinical trial sought to improve the existing autologous stem cell transplant (ASCT) protocol used to treat non-Hodgkin's lymphoma patients. The existing method involved removing healthy blood cells from a patient, treating the patient with chemotherapy and then re-injecting the patient with their removed cells to regenerate a healthy blood system. By simply increasing both the total amount of cells and the relative amount of a specific cell type (natural killer cells) that are harvested and re-injected, the success rate of the procedure is increased. For almost no cost or additional risk, the rate of durable remissions seen in patients can increase from 50% to 70%. These protocol improvements can save lives and reduce healthcare costs for patients who suffer from a variety of blood cancers. Almost 600,000 ASCTs are performed around the world each year. This success could save up to 180,000 lives per year!

CWR funding role: Participating funder

Publication:  Biology of Blood and Marrow Transplantation

Since publication:

→ Data are supporting a change in clinical practice

→ Data are supporting trials in other diseases using the same repurposing treatment

Sign up for our eNewsletter today!


First Name


Cures Within Reach

Illinois Science+Technology Park

8025 Lamon Avenue, Suite 440

Skokie, IL 60077



Sunday the 19th. copyright 2015 Cures Within Reach.